محصولات
Available Products
| # | Product Name | CAS No. | Pharmacopeia | Status |
|---|---|---|---|---|
| Diabetes | ||||
| 1 | Sitagliptin phosphate monohydrate | 654671-77-9 | USP | Available |
| 2 | Empagliflozin | 864070-44-0 | In-house | Available |
| 3 | Linagliptin | 668270-12-0 | In-house | Available |
| 4 | Gliclazide | 21187-98-4 | BP | Available |
| Immunology | ||||
| 1 | Apremilast | 608141-41-9 | In-house | Available |
| Cardiology | ||||
| 1 | Telmisartan | 144701-48-4 | USP | Available |
| 2 | Rosuvastatin calcium | 147098-20-2 | EP/BP | Available |
| 3 | Apixaban | 503612-47-3 | In-house | Available |
| 4 | Valsartan | 137862-53-4 | USP | Available |
| 5 | Amlodipine besylate | 111470-99-6 | USP | Available |
| Oncology | ||||
| 1 | Palbociclib | 571190-30-2 | In-house | Available |
| Neurology | ||||
| 1 | Levetiracetam | 102767-28-2 | BP | Available |
Under Development Products
| # | Product Name | CAS No. | Pharmacopeia | Status |
|---|---|---|---|---|
| Diabetes | ||||
| 1 | Orforglipron | 3008544-96-2 | In-house | Under Development |
| Immunology | ||||
| 1 | Upadacitinib hemihydrate | 2050057-56-0 | In-house | Under Development |
| Respiratory | ||||
| 1 | Montelukast sodium | 151767-02-1 | BP | Under Development |
| Infectious Diseases | ||||
| 1 | Levofloxacin hemihydrate | 138199-71-0 | USP | Under Development |
| Neurology | ||||
| 1 | Ozanimod hydrochloride | 1618636-37-5 | In-house | Under Development |
| 2 | Rimegepant sulfate | 1374024-48-2 | In-house | Under Development |
| Oncology | ||||
| 1 | Nintedanib esylate | 656247-18-6 | In-house | Under Development |
| 2 | Olaparib | 763113-22-0 | In-house | Under Development |
| Hepatology | ||||
| 1 | Resmetirom | 920509-32-6 | In-house | Under Development |
| Gastroenterology | ||||
| 1 | Vonoprazan fumarate | 881681-01-2 | In-house | Under Development |
